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Calcium channel  subunits are key modulators of
calcium channel function and membrane targeting of
the pore-forming 1 subunit. Here we show that an in-
vertebrate (Lymnaea stagnalis) homolog of P/Q- and N-
type calcium channels (LCav2), although colocalized
with  subunits in synapses of mature neurons, is phys-
ically uncoupled from the  subunits in the leading edge
of growth cones of outgrowing neurons. Moreover,
LCav2 channels that mediate transmitter release in ma-
ture synapses also participate in neuronal outgrowth in
growth cones. The differential association of  subunits
with synaptic calcium channels and those expressed in
emergent neuronal growth suggests that  subunits may
play a role in the transformation of Cav2 calcium chan-
nel function in immature neurons and mature synapses.
Members of the Cav2 calcium channel family are considered
essential triggers of synaptic transmission at vertebrate (1)
and invertebrate synapses (2–4). Like other types of high volt-
age-activated channels, Cav2 channels exist as macromolecular
complexes of a pore-forming 1 subunit and ancillary , 2-,
and possibly  subunits (5). The mammalian brain expresses
four different types of  subunits that interact to differentially
modulate 1 subunit function (6, 7). The functional effects of 
subunit coexpression include changes in the voltage depen-
dences and rates of activation and inactivation, plus an in-
crease in current densities (8–17). The latter observation has
been linked to the masking of an endoplasmic reticulum (ER)1
retention signal on the calcium channel 1 subunit (18). The
physiological importance of calcium channel  subunits is sup-
ported by studies involving mutant and knockout mice. For
example, a spontaneous mutation in 4 effectively leads to a
functional null mouse resulting in a lethargic phenotype with
impaired synaptic transmission (19). Alternatively, knockout of
3 inhibits the activities of neuronal L-type and N-type chan-
nels (20). However, because the central nervous system ex-
presses multiple  subunits, compensation by other  subunit
isoforms complicates the analysis of these phenotypes (21).
Moreover, synaptic nerve terminals frequently express both
N-type and P/Q-type calcium channels (22), each of which can
associate with all of the four  subunits (23–25). This combi-
natorial subunit complexity has hampered attempts to delin-
eate the precise fundamental roles of  subunits on synaptic
function (21).
In contrast, invertebrates express only a single representa-
tive of each of the three major calcium channel 1 subunit
isoforms and a singleton homolog of the  subunit (26). We
have reported recently the isolation and functional character-
ization of a Cav2 calcium channel homolog (LCav2) from the
mollusc Lymnaea stagnalis. We showed that LCav2 displays
functional properties that are reminiscent of mammalian N-
type calcium channels (27) and that this channel is essential for
synaptic transmission between identified Lymnaea neurons
(4). Like its vertebrate counterpart, LCav2 contains the -in-
teraction domain, a highly conserved region in the domain I–II
linker that is essential for interactions with calcium channel 
subunits (4, 27). Furthermore, the Lymnaea model system al-
lows for the in vitro reconstruction of identified synapses,
which are highly amenable for molecular and cellular manip-
ulation. These synapses are target cell-specific, require gene
transcription and de novo protein synthesis, are ultrastructur-
ally and electrophysiologically similar to those observed in vivo
(28, 29), and will establish appropriate synapses in vivo after
transplantation into the intact ganglia (28, 30). In this study,
we took advantage of this invertebrate model to elucidate fun-
damental aspects of  subunit physiology.
Here we report the isolation of the Lymnaea  subunit
(LCav), its functional characterization, and its distribution in
neurons. LCav caused neither a considerable alteration in
LCav2 calcium channel activity nor did it mediate an increase
in expression of LCav2. We show that besides their known
function in triggering neurotransmitter release, LCav2 chan-
nels are essential for proper synaptic outgrowth. However, in
terminal growth cones and nascent growth along major neu-
rites,  subunits are spatially and physically uncoupled from
LCav2 channels and not associated with neurite outgrowth. In
synaptic contacts, LCav2 channels associate with  subunits
that potentially are synthesized locally in distal neurites. This
local pool of neuritic  subunits may support the immediate
and cytoskeletal reorganization of the developing growth cone
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into a nascent synapse or the dynamic remodeling in mature
synapses.
EXPERIMENTAL PROCEDURES
Molecular Identification, Structural Analyses, and Preparation of
Lymnaea Genes for in Vitro Expression—The L. stagnalis calcium chan-
nel  subunit LCav (gi:29378324) was identified in a 418-bp PCR
product from fresh Lymnaea brain cDNA with the use of degenerate
primers (4). The isolated PCR product served as a probe to isolate a
full-length 1950-bp cDNA homolog coding for LCav (gi:29378324) from
Lymnaea brain cDNA libraries (Vrije Universiteit Amsterdam, The
Netherlands). Protein sequences of LCav and other Cav subunit ho-
mologs were aligned in PILEUP (GCG Wisconsin Package, Accelrys)
and imported into PAUP 4.0 to generate a consensus gene tree using the
Branch-and-Bound algorithm. The gene tree was tested for robustness
in 100 bootstraps and displayed in TREEVIEW 1.6.6 (Rod Page, Glas-
gow, Scotland, UK). A running window of average similarity of the
aligned genes was displayed using PLOTSIMILARITY (GCG Wisconsin
Package).
For in vitro expression, 5 NotI and 3 XhoI restriction sites were
incorporated into primers flanking the 568-amino acid coding region of
LCav for PCR cassette insertion into the mammalian expression vector
PMT2SX. The sequence immediately upstream from the start (ATG)
codon was also altered to include a consensus Kozak sequence
CGGCCGCCACC(ATG).
Transfection and Assessment of Function in Vitro by Patch Clamp
Electrophysiology—Heterologously expressed cDNAs encoding an en-
hanced green fluorescent protein marker (Clontech), a Cav2 1 subunit
from rat (rCav2.1, rCav2.2, and rCav2.3) or Lymnaea (LCav2a, Gen-
BankTM accession number AF484082), the rat 2-1 subunit, and either
no  subunit or one of the four rat  subunits (1b, 2a, 3, and 4) or the
Lymnaea  subunit (LCav) were transfected into human embryonic
kidney tsA-201 cells by using a standard calcium phosphate protocol
(27). Transfected LCav2a cDNA contained the first 44 amino acids
swapped with the homologous region of rat Cav2.1. We demonstrated
previously (27) that this alteration is one that is both necessary and
sufficient for membrane expression of LCav2a in human cell lines. The
activities of calcium channels were measured with barium as the charge
carrier via whole cell patch clamp using an Axopatch 200B amplifier
(Axon Instruments, Union City, CA), pCLAMP 9.0 software, after in-
cubation of transiently transfected cells at 28 °C for 2–4 days. All
solutions and recording procedures have been described previously (27).
Electrophysiological data were analyzed in Clampfit (pClamp 9,
Axon Instruments) and SigmaPlot 2000 (Jandel Scientific, SPSS Sci-
ence, Chicago). Steady state inactivation curves and macroscopic cur-
rent voltage relations were analyzed using a standard Boltzmann equa-
tion. A monoexponential fit of the raw data was used to derive time
constants for inactivation and for recovery from inactivation. Data are
expressed as means  S.E., with numbers in parentheses, as displayed
in the figures, reflecting the numbers of experiments. Statistical anal-
ysis was carried out using Sigmastat (Jandel Scientific). Differences
between mean values from each experimental group were tested using
paired and unpaired Student’s t tests or one-way analysis of variance
and were considered significant if p  0.05.
Polyclonal Antibody Synthesis and Immunolocalization of Lymnaea
LCav and LCav2 in Cultured Neurons and Transfected Cell Lines—
The peptide SLDEEKEALRRET corresponding to amino acids 64–76
(see Fig. 1A) was used as the antigen for the LCav peptide antibody.
Matrix-assisted laser desorption ionization-mass spectrometry and an-
alytical high pressure liquid chromatography were used to confirm the
purity of the peptide (Henk Hilkman, Netherlands Cancer Institute,
Amsterdam, The Netherlands). Rabbits were immunized for a 4-week
period with adjuvants and antigen conjugated to carrier protein (Wash-
ington Biotechnology Inc., Baltimore). Rabbit antiserum was enzyme-
linked immunosorbent assay titered at 1:50,000 and measured for im-
munoreactivity by spot blot. A peptide polyclonal antibody for the
LCav2 calcium channel was derived from the antigenic sequence KAED-
NENDSEQNDND, coding for amino acids 418–432 of the cytoplasmic
I–II linker. This peptide coupled to carrier was raised either as anti-
rabbit (27) or anti-chicken.
Western blot samples consisted of proteinaceous extracts of har-
vested transiently transfected or untransfected tsA-201 cells incubated
for 4 days at 37 °C or freshly isolated Lymnaea central ring ganglia. Cell
samples were collected on ice in 500 l of 0.32 M sucrose and the
protease inhibitors pepstatin A (1 mg/ml), aprotinin (1 mg/ml), leupep-
tin (1 mg/ml), pefabloc SC (0.2 mM), benzamidine (0.1 mg/ml), and the
calpain inhibitors I and II (8 mg/ml each). After centrifugation, super-
natants of proteinaceous extracts were separated by 5% SDS-PAGE and
transferred (40 V for 16 h) onto a Immobilon polyvinylidene difluoride
membrane (Millipore). After air-drying for 2 h, the membranes were
blocked for nonspecific binding in 5% milk, 0.1% Tween 20, PBS solu-
tion (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4 (pH
7.3)) and incubated overnight at 4 °C in primary antibody (1:2000). The
membranes were washed five times in PBS/Tween 20 followed by incu-
bation for 1 h with goat anti-rabbit or donkey anti-chicken IgG-coupled
horseradish peroxidase in 5% milk/PBS/Tween 20 and five washes in
PBS/Tween 20. Antigen was detected using chemiluminescent horse-
radish peroxidase substrate (ECL, Amersham Biosciences) and visual-
ized following exposure to Amersham Hyperfilm-MP.
Neurons (VD4, LPeD1, RPeD1, CGCs) that form identified synapses
in vitro were isolated from the Lymnaea central ring ganglia by using
established protocol (4, 28) and plated on poly-L-lysine-coated substrate
for 48 h in brain-conditioned medium at a density to foster both growth
cone development in singletons and synaptically connected neurite-
neurite pairs in the same dish. Immunolabeled samples of untrans-
fected/transfected tsA-201 and identified Lymnaea cultured cells were
fixed using 1% paraformaldehyde, permeabilized, and blocked in 0.1%
Triton X-100, 1 g/liter bovine serum albumin containing 0.05 M Tris
buffer, pH 7.4. Immunolabeled samples were washed extensively in
Tris/bovine serum albumin/Triton followed by washing in Tris buffer
(27). Immunolabeled samples were exposed to primary (1:2000 dilution)
and fluorescently conjugated secondary antibodies overnight at 4 °C for
45 min at room temperature, respectively, to limit background staining.
Background staining was assessed by preincubating the peptide poly-
clonal antibody at 1:2000 dilution with the antigenic peptide (5 g/ml)
overnight or by substituting the primary antibody for anti-rabbit or
anti-chicken preimmune serum at 1:2000. Fluorescently conjugated
secondary antibodies for immunostaining IgG (HL) anti-rabbit LCav,
and anti-rabbit or anti-chicken IgG (HL) LCav2 consisted of Alexa
Fluor 555 (red) donkey anti-rabbit IgG or Alexa Fluor 488 (green) goat
anti-chicken IgG at 1:400 dilution (Molecular Probes, Inc., Eugene, OR).
Prepared samples were wet-dried and mounted in fluorescence antifad-
ing media (Fluorsave, Calbiochem). Images were visualized and ana-
lyzed on an Olympus confocal microscope.
In Situ Hybridization and Immunolocalization in Lymnaea Central
Ring Ganglia Sections—Lymnaea central nervous systems were fixed
in Bouin’s fixative (16–24 h) and, after dehydration with ethanol,
embedded in paraffin. Consecutive 7-m sections were adhered to Su-
perfrost™ microscope slides.
LCav RNA was detected in tissue sections with run-off antisense
RNA, complementary to the coding region of amino acids 114–354 (720
bp) of LCav. An antisense construct was synthesized in the PCR by
using forward primer with a 5 incorporated KpnI site, GGGGTACCT-
GGCTGTGCGGTGTCATTTGGGG, upstream of DNA position 505 bp
and 3 reverse primer, GATTGTGTCACAGTCCAACACCAC, ending at
position 1260 bp just downstream of a unique SacI restriction site at
1229 bp. The resulting PCR product after KpnI-SacI digestion was
inserted into pBluescriptII KS. EV3 and EV2 primers were used to
amplify the 721-bp PCR product containing the LCav fragment
flanked by T7 and T3 promoters of pBluescript KS. RNA was synthe-
sized from this linear PCR template using T7 (for sense probe) and T3
(for antisense probe) RNA polymerase (Roche Applied Science). RNA
probes were then labeled with 35S-dUTP (PerkinElmer Life Sciences)
rendering specific activities of 50000 cpm/pmol DNA. The 10 fmol/l
probe in a standard hybridization mixture was incubated overnight at
37 °C and then washed with increasing stringencies at 60 °C. Slides
were subsequently dipped in Eastman Kodak NTB2 emulsion and de-
veloped after 7 days of autoradiographic exposure.
Assessment of RNA Transcript Levels and Local Protein Expression
in Isolated Neurites—Isolated Lymnaea CGC neurons were isolated and
subsequently cultured on a poly-L-lysine-coated adhesive substrate as
described previously (31). Briefly, neurons were plated with long neu-
ritic stumps to maximize neurite extension without allowing neuronal
intra-connections (autapses) or inter-connections with other neurons
(synapses). After 2 days of culturing, somata were severed from neu-
rites with a sterile glass pipette 20–40 m from the somata and then
removed from the dish.
For reverse Northern blot analyses, dishes containing soma-ablated
neurites were rinsed three times in sterile saline before cultured neu-
rites were bathed and lifted from the adhesive substrate by trituration
in Trizol reagent (Invitrogen). Subsequent to Trizol extraction, total
RNA (200 ng) was amplified by SMART cDNA synthesis (zco;clontech-
Clontech). Blots were probed with 32P-labeled/PCR-amplified cDNA
inserts spotted with DNA plasmids (200 ng) on a Hybond-N nylon
membrane (Amersham Biosciences) coding for DNA fragments of Lym-















naea calcium and potassium channel clones (GenBankTM accession
number, corresponding to the amino acid sequences, LCav1 (AF484079,
373–670), LCav2 (AF484082, 302–621), LCav3 (AF484084, 848–1111),
LCav (AF484087, 285–433), LKv2.1 (AY551910), and LKv3.1
(AY551911), and subsequently imaged via a PhosphorImager (Bio-Rad).
LKv2.1 and LKv3.1 are novel sequences accompanying this paper that
were isolated from fresh Lymnaea cDNA by degenerate PCR.
To assess local protein synthesis of LCav mRNA in soma-ablated
neurites, an HA-tagged LCav construct was designed by nested PCR
insertion of TACCCATACGATGTTCCAGATTAC, coding for an HA
epitope (YPYDVPDY) just downstream of the start codon of full-length
LCav in pBluescript II KS. Linearized template was created by
digestion of post-3-untranslated region of linearized HA-tagged LCav
with KpnI enzyme. In vitro transcribed, capped, and poly(A)-tailed RNA
was synthesized from 3 linearized HA-tagged LCav construct plasmid
using the mMessage mMachine T7 Ultra kit (Ambion, Austin, TX).
HA-tagged LCav mRNA construct was microinjected into soma-ab-
lated neurites, followed by a 12-h incubation to allow heterologous
expression of HA-tagged protein. These samples were then fixed and
stained for HA epitope using a rat monoclonal antibody (clone 3F10,
Roche Applied Science), followed by Alexa Fluor 488-conjugated chicken
anti-rat IgG (HL), using the immunocytochemical procedure de-
scribed above.
Gene Knockdowns in Cultured, Identified Lymnaea Neurons—Gene
knockdowns were carried out on isolated CGC neurons, plated on non-
adhesive, hemolymph-treated glass coverslips, and bathed in brain-
conditioned medium with 10 M antisense/mismatch DNA oligonucleo-
tide probes (4, 32) or 10 g of double-stranded RNA (4). After 3 days of
incubation, the treated neurons were transferred to poly-L-lysine-pre-
treated glass coverslips bathed in fresh brain conditioned medium.
These neurons were incubated for 48 h in the dark to maximize sprout-
ing of neurites and then fixed in 1% paraformaldehyde and immuno-
stained for detection of LCav2 and LCav protein expression by confocal
microscopy. Extension of primary neurites beyond five somata lengths
was considered normal, control neurite growth.
15-mer antisense ACAAGACGACCTATC spanned a region of a
highly conserved sequence at amino acids 136–141, coding for WIGRLV
at position 574–588 bp in LCav. Mismatch probes for LCav consisted
of 3 base changes to the antisense sequence, ACGAGACCACCGATC
(changed nucleotides are underlined). Antisense/mismatch probes were
prefiltered through a 0.8-m filter, boiled for 2 min, and cooled on ice
before incubation with neurons. Fluorescence intensities of antisense
versus mismatch LCav samples were quantified in optical density
units in a 200  200 m area encompassing each neuron centered in
view using ImageJ software (National Institutes of Health).
As described previously (4), RNA interference probes consisted of a
mixture of double-stranded RNA synthesized by T7/T3 transcription in
both sense/antisense strands (MEGASCRIPT; Ambion, Austin, TX) of
template inserted between T7 and T3 promoters in Bluescript II KS
vector. The template coded for the II–IIII loop in LCav2a (2237–2710)
and LCav2b (2237–2761), or a negative control consisting of a fragment
of the 3-untranslated region of LCav2 that lies between natural PstI
and HindIII sites (6709–7278). All of the experiments involving gene
knockdown were carried out in a double blind fashion.
RESULTS
Lymnaea Neurons Express a Cav Subunit—A full-length
1950-bp cDNA homolog coding for a 568-amino acid calcium
channel  subunit (LCav) was isolated from an L. stagnalis
brain cDNA library (Fig. 1A). Other invertebrates as well as
completed genomic sequences of Caenorhabditis elegans and
Drosophila reveal a similar singleton homolog that represents
the four known mammalian  subunit isoforms (i.e. 1 through
4, Fig. 1B). LCav and mammalian  subunits display a sim-
ilar architecture of three variable regions separated by two
highly conserved regions, in which LCav and mammalian 
subunits share 80 and 89% sequence identity, respectively (Fig.
1, A and C). The  subunit core is considered to resemble
central modules of membrane-associated guanylate kinase ho-
mologs (33–35), with conserved and interacting SH3 and gua-
nylate kinase domains, and a variable HOOK region that splits
the SH3 fold (Fig. 1, A and C). Residues in the guanylate kinase
domain contribute to form a deep, hydrophobic groove for high
affinity binding of high voltage-activated calcium channels (33,
35), which are highly conserved residues among invertebrate
and mammalian  subunits (Fig. 1A, black residues).
The striking conservation of the structural core of all inver-
tebrate and vertebrate  subunits suggests a functional equiv-
alency of the four mammalian  subunits with the singleton
invertebrate homolog. At vertebrate presynaptic terminals, all
four mammalian  subunit isoforms are considered potential
regulators of the two synaptic calcium channel 1 subunits,
P/Q-type (Cav2.1) and N-type (Cav2.2). Like the singleton 
subunit gene, invertebrates bear a single Cav2 homolog that
represents both mammalian P/Q-type and N-type synaptic cal-
cium channels and that is essential for synaptic transmission
(26). This lack of combinatorial complexity of multiple calcium
channels and  subunits provides for a unique opportunity to
delineate the fundamental neurophysiological function of the 
subunit.
Distribution of LCav in Lymnaea Brain—To assess the dis-
tribution of LCav and its putative colocalization with the
LCav2 calcium channel 1 subunit in Lymnaea brain, we gen-
erated a polyclonal peptide antibody designed against the 
subunit raised in rabbit (see Fig. 1, A and C), and an anti-
chicken LCav2 antibody, whose epitope specificity was charac-
terized previously from rabbit (27). As shown in Fig. 2, the
anti-rabbit  subunit (Fig. 2A) and anti-chicken LCav2 calcium
channel 1 subunit (Fig. 2B) antibodies recognized appropriate
sized bands in Western blots containing extracts from either
transfected tsA-201 (LCav) or Lymnaea central nervous sys-
tem (LCav and LCav2 1). Whereas the  subunit antibody
recognized a single, expected 62-kDa protein, two bands rep-
resenting the previously described LCav2 isoforms (4), a full-
length (243 kDa) variant, LCav2a, and a short, C-terminally
truncated (185 kDa) variant, LCav2b, were identified with
the anti-chicken LCav2 1 subunit antibody. Additionally, both
antibodies produced robust membrane staining in tsA-201 cells
cotransfected with LCav and the LCav2 1 subunit (Fig. 2C).
The two subunits showed overlapping distribution in the
plasma membrane, consistent with the formation of a channel
complex. Overnight preincubation of the antibody with 5 g/ml
peptide used as the epitope for antibody generation of LCav2 or
LCav with their primary antibody removed virtually all of the
staining in both tsA-201 cells and in cultured neurons (not
shown). Specificity was further confirmed by the dense LCav2
and LCav antibody costaining in cultured neurons (Fig. 4,
C–E) compared with preimmune controls (Fig. 4, A and B).
Collectively, these data are consistent with findings in verte-
brate neurons that presynaptic calcium channels are com-
plexed with ancillary  subunits (24, 25).
LCav Weakly Regulates LCav2 Properties—Despite the ap-
parent overlap in membrane expression shown in Fig. 2C, there
was a striking lack of regulation of biophysical properties of
LCav2 by LCav. In contrast to what has been reported for
mammalian  subunits (8–17), LCav did not affect the voltage
dependences of activation (Fig. 3A) and inactivation (Fig. 3C),
and there was no effect on the kinetics of recovery from inac-
tivation (Fig. 3D). Moreover, there was no effect on current
densities (Fig. 3B), suggesting that LCav may not affect mem-
brane expression of the LCav2 1 subunit. The only measurable
effect of LCav was a slight but statistically significant slowing
of the inactivation kinetics (Fig. 3, E and F). We therefore
conclude that LCav2 activity is only weakly regulated by
LCav.
To rule out the possibility that LCav was perhaps not func-
tionally expressed in tsA-201 cells, and to determine whether
LCav2 simply lacked a general ability to functionally interact
with  subunits, we examined various combinations of rat and
Lymnaea 1 and  subunits. As shown in Fig. 3, mammalian 















FIG. 1. Structural comparisons between  subunit isoforms. A, alignment between Lymnaea Cav and the four rat  subunit subtypes.
Identical amino acids are indicated by dark outlined gray boxes and similar ones by lighter colored gray boxes. Putative locations of  helices and
 sheets are provided from current structural models (33). Residues lining a hydrophobic groove of  subunits that are considered to interact
directly with 1 subunits of Cav1 and Cav2 calcium channels are darkly shaded conserved residues (33, 35). B, most parsimonious gene tree of 
subunits generated from the four rat orthologs and singleton invertebrate representatives. Numbers at branch node represent robustness of
branches in 100 bootstraps. C, running window of similarity among invertebrate and rat homologs illustrated in B. Note the highly conserved core
of  subunits in SH3 and guanylate kinase (GK) domains and the variable HOOK domain that splits the SH3 domain. Highly divergent exons 1,















subunit subtypes potently regulated LCav2 function in a man-
ner consistent with what has been reported previously for other
mammalian calcium channels and  subunits (8–16). These
changes include the following: 1) mild hyperpolarizing shifts in
half-inactivation potential with r1b, r3, and r4 and depolar-
izing shifts with r2a (Fig. 3C); 2) 3–6-fold increases in peak
current amplitude; 3) pronounced speeding of recovery from
inactivation with most rat  subunits (Fig. 3D); and 4) signif-
icant changes in inactivation kinetics ranging from speeding
with 3 and 1b to slowing 2a (Fig. 3E). Conversely, the coex-
pression of LCav significantly (p  0.05) increased the peak
current amplitudes of rat Cav2 channels (Cav2.1, from 296.7 
87.8 (n  7) to 3060.2  1359 pA (n  13); Cav2.2, from 60.0 
12.5 (n  15) to 610.5  249.2 pA (n  13); Cav2.3, from 136.1 
20.2 pA (n  12) to 1123.2  334.1 pA (n  13)), in addition to
slowing the inactivation kinetics of all rat Cav2 channels (see
Fig. 3G for example). These data indicate that LCav2 calcium
channels are susceptible to regulation by mammalian (but not
invertebrate)  subunits, and more importantly, LCav sub-
units are indeed functional in tsA-201 cells.
LCav2 and LCav Distribution in Neurons—The relative
lack of effects of the expression of LCav subunits on the
biophysical properties and current amplitudes of LCav2 raises
the question as to whether  subunits associate with the LCav2
calcium channel in neurons. As shown in Fig. 4, antibody
costaining of LCav2 channels and LCav reveals an overlap-
ping distribution (yellow color) in synaptically connected iden-
tified Lymnaea neurons (Fig. 4C) with “railroad track”-like,
membrane-delimited costaining of LCav2-LCav at higher
magnification (Fig. 4, E and F). This indicates that in mature
neurons, LCav2 calcium channels and  subunits are likely in
a complex, reminiscent of what is known to occur in vertebrate
neurons and consistent with the dogma that calcium channels
and  subunits assemble in the ER and are cotargeted to the
plasma membrane (18).
Secondary and tertiary neurites are ladened with extensive
varicosities with intense LCav2-LCav colabeling, pretermi-
nally and at sites of synaptic contact (Fig. 4D). Most interest-
ingly, new neurite outgrowth manifested in filopodia tufts
along major neurites (Fig 4E, magnified in Fig. 4F) or emergent
growth cones (Fig. 5A) contain mostly LCav2 staining (green)
with a striking absence of considerable LCav staining (red). In
terminal growth cones, a nonoverlapping distribution of LCav2
and LCav is clearly evident. In a “filopodial” type of growth
cone, associated with rapidly migrating neurites (36), LCav
staining emerges from the back central lamellipodium, and
splays into the periphery (Fig. 5, B and C). In contrast, LCav2
is expressed in peripheral lamellipodia of growth cones (Fig. 5,
5, 6, and 13 are numbered according to the rat 3 gene (6). Alternatively spliced long and short (a/b) isoforms exist for exons 1 and 6. The antibody
epitope for LCav is indicated by dashed box in A. GenBank
TM (gi) sequences for analyses includes rat isoforms: 1b, 8393060; 2a, 16758716; 3,
1705686; 4, 423788; L. stagnalis, 29378325; Loligo bleekeri 19911801; Drosophila melanogaster 6646874; C. elegans 17506267; Schistosoma
mansoni 15283999; Cyanea capillata 2654496.
FIG. 2. Localization of LCav and
LCav2 channels with 1:2000 dilution
of anti-rabbit LCav and anti-
chicken LCav2 antibodies in Western
blots. A, identification of appropriately
sized bands with LCav antibody in lanes
containing protein extracts from LCav-
transfected tsA-201 cells and Lymnaea
brain versus a lane containing protein ex-
tracts of mock-transfected tsA-201 cells.
B, high molecular weight bands of ex-
pected sizes for the identified long and
short LCav2 isoforms, LCav2a and
LCav2b, respectively, in lane of Lymnaea
brain extract labeled with LCav2 anti-
body. C, overlapping (yellow) membrane-
delimited staining of tsA-201 cells co-
transfected with LCav and LCav2
calcium channels labeled with fluorescent
secondary conjugates that recognized an-
ti-chicken LCav2 (green) and anti-rabbit
LCav (red).















FIG. 3. A–E, effects of invertebrate LCav or mammalian Cav1-4 on biophysical characteristics of LCav2 calcium channels expressed in tsA-201
cells. A, ensembles of whole cell barium current voltage relations, fitted by the Boltzmann equation. B, peak current amplitude of barium currents
obtained at a test potential of 20 mV from a holding potential of 	80 mV. C, half-inactivation potentials (Vh) obtained from Boltzmann fits to
steady state inactivation curves obtained at a test potential of 20 mV. D, monoexponential fit of the time course of recovery from inactivation.
Note that the data obtained in the presence of rat 2a are not adequately described by a monoexponential fit. E, representative whole cell LCav2
current traces scaled to overlap at peak to illustrate effects of various  subunits on a time course of inactivation over a 200-ms test pulse. F, voltage
dependence of the time constant of inactivation of LCav2 barium current () obtained at a holding potential of 	100 mV in the presence and absence
of LCav. G, representative peak current record obtained with rat Cav2.3 in the presence and the absence of LCav at a test potential of 10 mV.















B and C) and filopodia emerging from both the peripheral and
central region of lamellipodia (Fig. 5D). This distinct pattern
seen with LCav2 and LCav seems reminiscent of the distinct
expression patterns observed with F-actin and microtubule
staining (37). In larger, “lamellipodia”-type growth cones, as-
sociated with slow migrating or paused neurites (38), a bright
halo of LCav2, actin-like staining in filopodia forms around the
central region of the growth cone, where LCav subunits form
a microtubule-like looped pattern (Fig. 5, E and F). These data
indicate that although synaptically paired neurons appear to
contain complexes of Cav2 calcium channel 1 subunits and 
subunits, the growth cone periphery and filopodia only contain
the 1 subunit. These data thus suggest that 1 and  subunits
may not be coassembled in the ER and transported to the
membrane as stable complexes during neuronal outgrowth or,
alternatively, that coassembled subunits subsequently segre-
gate upon their arrival in growth cones.
Role of LCav2 Channels in Growth Cones—At synaptic nerve
terminals, LCav2 channels are essential for neurotransmitter
release (4) and are colocalized with  subunits. However, the
function of ( subunit uncoupled) LCav2 channels in growing
neurons is not known. To address this issue, we treated non-
adherent cultured Lymnaea neurons with LCav2 RNAi or con-
trol RNAi for a period of 3 days, plated the neurons on adhesive
substrate for 2 days to enable neurite outgrowth, and then
post-stained for immunodetection of LCav2 and LCav. Control
RNAi-treated neurons (n  6) had a typical morphology with
wide, rib-like, primary neurites and secondary neurites lad-
ened with varicosities and extensions that form autapses or
synapses (Fig. 6, A and B). In addition, robust colocalization of
LCav2 and LCav was apparent. In the LCav2 RNAi-treated
group, we observed a dramatic reduction of LCav2 antibody
staining compared with control RNAi-treated neurons. All neu-
rons adhered well to the substrate, suggesting that this subunit
is not required for calcium-induced cell adhesion. However,
LCav2 knockdown either eliminated all neurite growth (n  8)
or produced neurons with an aberrant, stunted morphology
(n  10) with either a veil-like sheath or hair-like neurites
emerging from the somata (Fig. 6, C and D). In these neurons,
 subunit expression was less evident in the periphery and
FIG. 4. Antibody immunolocalization of the LCav2 calcium
channel (anti-chicken) and LCav (anti-rabbit) in synaptically
connected, identified Lymnaea neurons in 2-day primary cul-
tures. LCav2 and LCav are identified by fluorescent secondary conju-
gates Alexa Fluor 488 (green, top left panel) and 555 (red, top right
panel), respectively (A–F). Superimposed antibody staining (yellow)
displayed at bottom (A–F). Control staining with anti-chicken (A) or
anti-rabbit (B) preimmune serum at 1:2000 dilution. Note the relative
absence of staining under these control conditions. C, dense, double-
stained LCav2 and LCav overlap (yellow) of synaptically paired neu-
rons (20); D, in preterminal varicosities of terminal neurites (40). E,
40 magnified sample of somata and its primary neurite offshoots; F,
magnification of neurite with filopodia tufts (white arrow, in E).
FIG. 5. Antibody immunolocalization of LCav2 calcium chan-
nel (anti-chicken LCav2) and  subunit (anti-rabbit LCav) in
terminal growth cones of identified Lymnaea neurons in 2-day
primary cultures. LCav2 and LCav are identified by fluorescent
secondary conjugates Alexa Fluor 488 (green, top left panel) and 555
(red, top right panel), respectively (A–F). Superimposed antibody stain-
ing (yellow) is displayed in the bottom panel (A–F). A, growth cone
emerging from primary neurite (60) and growth cones at terminal
neurites (B  40; C–F  100). Dense LCav2 and LCav double-
labeled staining (yellow) is apparent in preterminal varicosities, but
nonoverlapping stain of LCav2 (green) and LCav (red) is seen in
rapidly migrating growth cones (B–D) where LCav is splayed from the
central lamellipodium into periphery. LCav2 staining in filopodia and
the peripheral lamellipodium appears as a halo surrounding LCav
staining with apparent looped morphology in “paused”-type growth
cones (E and F).















more pronounced in the soma where L-type (LCav1) calcium
channels are likely to be expressed. Overall, these data suggest
that LCav2 calcium channels are required for outgrowth during
neuronal differentiation. Moreover, the observation that RNAi
depletion of LCav2 channels virtually abolished antibody stain-
ing further supports the specificity of the LCav2 anti-chicken
antibody.
Because LCav2 channels at the tips of outgrowing neurons
are not complexed with  subunits, one might expect that
knockdown of LCav should not affect neuronal outgrowth.
Repeated attempts with different probes for a gene knockdown
using RNAi of LCav subunits did not result in a substantial
reduction in LCav immunolabeling. Instead, we resorted to an
antisense approach that was shown previously to lead to knock-
down of mammalian  subunits (39, 40) in cultured rat dorsal
root ganglion neurons. As shown in Fig. 7, B and C, antisense
knockdown (n  8) substantially, albeit not completely, re-
duced detectable LCav immunostaining compared with mis-
match controls (n  8). Under antisense conditions, neuronal
outgrowth in treated cells was indistinguishable from control
conditions (Fig. 7A), indicating that LCav subunit does not
appear to be essential for neurite outgrowth.
Local Synthesis of LCav in Neurites—Our data suggest that
the  subunit plays an important role upon synaptic contact,
where neurites undergo cytoskeletal rearrangement to form
synaptic terminals, far from the distant somata. In this con-
text, axons may perhaps have their own mechanism for provid-
ing a rapid and ample supply of  subunits for the stabilization
of calcium channel complexes upon synapse formation or syn-
aptic remodeling during neuronal plasticity (for review see
Refs. 41 and 42). To determine whether LCav could be ex-
pressed locally to associate with LCav2 and modulate its activ-
ity at synaptic terminals, we examined the localization of
LCav message with radiolabeled antisense RNA. As shown in
Fig. 8A, this analysis revealed typical somatic localization for
LCav mRNA in cross-sections of the cerebral ganglion (Fig.
8A, s) and absence of detectable staining with a sense radiola-
beled probe (not shown). Although not readily abundant, 
subunit RNA could be found extrasomatically in neurites (be-
tween white arrows, Fig. 8A). To confirm the presence of LCav
mRNA outside the cell body, somata were excised by glass
pipette from sprouting cultured neurites of 40 identified Lym-
naea (CGC, VD4, and LPeD1) neurons. Following the removal
of somata, culture dishes containing isolated neurites were
rinsed thoroughly, and RNA was extracted, PCR-amplified in a
modified Eberwine protocol (43), and end-labeled to probe a
membrane spotted with plasmids encoding for fragments of
various LCav channel subunits and two of the known Lymnaea
Kv channel isoforms. By using this method, a potassium chan-
nel LKv2.1 (Shab) and LCav were detected on the blot, but
surprisingly, none of the three known calcium channels (i.e.
LCav1, LCav2, and LCav3) hybridized to neurite-derived la-
beled cDNA nor to LKv3.1 (KShaw). These data indicate that
the LCav subunit mRNA is present in outgrowing neurites
and raises the possibility that LCav subunits might be locally
translated upon synapse formation. To test this possibility, we
generated a hemagglutinin (HA)-tagged LCav construct. HA-
LCav mRNA was injected into soma-ablated neurites (Fig. 8,
C–E) and monitored for expression with rat HA monoclonal
antibody after a 12-h incubation. As shown in Fig. 8F, HA
antibody staining in isolated, soma-ablated neurons was de-
tected and overlapped with the distribution of native  sub-
units identified with the LCav antibody (Fig. 8, G and H). The
greatest density of  subunit staining was found at the site of
mRNA injection (Fig. 8, E and F). In contrast, soma-ablated
neurites that were not injected with HA-LCav mRNA were not
subject to detectable HA antibody staining (data not shown).
These data support the idea that LCav subunits can be locally
synthesized for possible complex formation with calcium chan-
nels in nascent synapses or after synaptic remodeling.
DISCUSSION
We present several novel findings concerning LCav2 chan-
nels and their association with  subunits. First, the singleton
representative of  subunits in Lymnaea neurons was not ca-
pable of strongly modulating the biophysical characteristics
nor the whole cell current amplitude of LCav2 channels in
tsA-201 cells, suggesting that the fundamental role of this
subunit may be unrelated to altering channel function per se.
Whether this absence of strong modulation is also a character-
istic of the other high voltage-gated channel in Lymnaea,
LCav1 is not addressed here. Second, although LCav2 and
LCav colocalize in mature, synaptically connected neurons,
the LCav2 1 subunit is decoupled from the  subunit in ter-
FIG. 6. Identified cultured Lymnaea
neurons treated with control (A and
B) or LCav2 (C and D) RNAi knock-
down. A and B, control RNAi neurons
show wide, rib-like, primary neurites and
secondary neurites ladened with varicos-
ities and extensions that form autapses or
synapses. A contains bright field view,
LCav2 (green) alone, LCav (red) alone,
and superimposed antibody staining (yel-
low). C and D, LCav2 RNAi-treated neu-
rons display an aberrant, stunted mor-
phology with either a veil-like sheath (C)
or hair-like neurites (D) emerging from
the somata. Superimposed antibody
staining of LCav2 and LCav are dis-
played in the insets (C and D).















minal growth cones and nascent growth along major neurites.
Third, the message for the  subunit was detected outside the
cell soma and can be locally translated in neurites. Finally, the
expression of a calcium channel subtype that is normally asso-
ciated with neurotransmitter release is essential for appropri-
ate neuronal outgrowth.
It is well established that presynaptic (i.e. Cav2) voltage-
gated calcium channels can tightly associate with ancillary 
subunits. Localization with specific antibodies and mRNA
analyses revealed that neurons express all of the known 
subunit genes (i.e. 1 to 4) (23–25), and each of these different
 subunit isoforms can, at least in transient expression sys-
tems, functionally associate with both N-type (Cav2.2) and
P/Q-type (Cav2.1) calcium channels (8, 12, 14), the major cal-
cium channels involved in the release of neurotransmitters
from presynaptic nerve termini (1). In expression systems, 
subunit coexpression has been shown to affect not only the
biophysical properties of various calcium channel 1 subunits
(such as activation and inactivation) but, perhaps more impor-
tantly, to promote increased current densities (for reviews see
Refs. 6 and 7), suggesting a role of  subunits in membrane
trafficking of the 1 subunit (18). The functional significance of
 subunits in neurons is further supported by analyses of
knockout and mutant mice (5). Knockout of 3 reduces the
activities of neuronal L-type and N-type channels (20). The
lethargic mouse, an effective 4 null mutant, is characterized
by seizure activity and ataxia; however, the density of presyn-
aptic calcium channels is not affected possibly because of com-
pensation from other  subunit subtypes (19, 44). Indeed, the
combinatorial complexity of multiple  and 1 subunits has
prevented detailed insights into the precise function of  sub-
units in synaptic terminals in vivo (21).
Unlike the four vertebrate  subunit genes, only singleton
homologs have been identified in sequenced invertebrate ge-
nomes (Drosophila and C. elegans) and six other invertebrates
from five diverse phyla (see Fig. 1B).  subunits have been
linked with other gene families to a HOX gene cluster, whose
different subtypes, like 1 through 4 are spread between four
tightly packed paralogous segments, which likely arose
through two rounds of duplication from a linked cluster of a
single, ancestral invertebrate-type gene (45). These data are
thus consistent with the presence of the  subunit singleton
identified in the Lymnaea brain. Furthermore, in repeated
attempts, we failed to isolate a second Lymnaea  subunit
isoform using degenerate PCR of freshly isolated cDNA or
hybridization screening of cDNA libraries. As with the  sub-
unit, invertebrates (i.e. C. elegans, Drosophila, and Lymnaea)
express only a single Cav2 homolog, which represents structur-
ally and functionally the vertebrate Cav2.1, Cav2.2, and Cav2.3
calcium channels (2–4). Because of the reduced complexity,
invertebrates such as Lymnaea therefore have the capacity to
provide unique insights into the roles of calcium channel 1 and
 subunits in synaptic physiology.
We have recently shown that LCav2 calcium channels are
essential for synaptic transmission at cholinergic synapses be-
tween identified Lymnaea neurons and, specifically, that this
involved a splice isoform of LCav2 that is capable of interacting
with the scaffolding proteins Mint-1 and CASK (4). Together
with work in rat hippocampal neurons (46), this suggested that
membrane-associated guanylate kinase scaffolding proteins
with PDZ, SH3, and guanylate kinase domains such as CASK
are likely involved in targeting and stabilizing Cav2 calcium
channels to synaptic contacts. It is interesting to note that
calcium channel  subunits also contain membrane-associated
guanylate kinase-like SH3 and guanylate kinase domains (33–
35), raising the possibility that secondary interactions of 
FIG. 7. Identified Lymnaea culture neu-
rons treated with mismatch (A) or anti-
sense (B) LCav. Each panel contains a
bright field view and immunodetection of
LCav2 (green), LCav (red), and superim-
posed antibody staining (yellow). Repre-
sentative sample illustrates substantial
reduction of detectable LCav immuno-
staining with antisense (B) compared
with mismatch controls (A) with no meas-
urable effect on neurite outgrowth. C, flu-
orescence intensities of antisense versus
mismatch LCav antibody staining were
quantified in optical density units in a
200  200 m area encompassing each
neuron centered in view.















subunits with scaffolding proteins may aid in stabilizing and
anchoring of LCav2 calcium channels in synaptic terminals.
In contrast, nascent growth along major neurites contained
LCav2 channels in filopodia without associated  subunits.
Indeed, there was a clear separation of 1 and  subunits in
terminal growth cones, and knockdown of the  subunit did not
affect neuronal growth per se, suggesting that  subunits do not
play the same role as LCav2 channels during neurite out-
growth. The expression pattern of 1 and  subunits, respec-
tively, bore a striking resemblance to those described previ-
ously for actin and tubulin (37, 47). It is thus tempting to
speculate that targeting of 1 and  subunits to their appro-
priate positions in growth cones could be mediated through
interactions with these cytoskeletal elements. Actin and micro-
tubule dynamics are associated with cellular processes that
involve structural rearrangements, such as cell motility and
division, and they enable rapid intracellular reorganization in
shape and direction in growth cones in response to external
cues (47). A close association of  subunits and LCav2 channels
with these motile proteins would result in their redistribution
along with the dynamic shape and direction changes in growth
cones. Although we do not have any experimental evidence that
calcium channel subunits are directly associated with actin and
tubulin, there are at least some indications from the literature
in support of such a mechanism. For example, CASK, which
physically binds to Cav2 calcium channels, is indirectly coupled
to actin/spectrin microfilaments (48). Moreover, Gem, a small
GTP-binding protein, localizes with actin and microtubules
(49) and can associate with mammalian calcium channel 
subunits, rendering them inoperative. As a consequence, acti-
vated Gem will inhibit mammalian calcium channels (50). It is
possible that similar cytoskeletal linked regulatory proteins
may modulate the interactions between Cav2 channels and 
subunits.
The observation that knockdown of the LCav2 1 sub-
unit resulted in drastically impaired neuronal growth is con-
sistent with observations from a Drosophila Cav2 mutant
(Dmca1ANT27) that produces a 35% reduction in terminal
branching in neuromuscular junction synapses, and a reduced
number in varicosities (51). Similarly, in Cav2.1 mouse mu-
tants such as the Rocker mouse, Purkinje neurons show a
dramatic reduction of dendritic arborization (52). In contrast,
the 4 lethargic null mutant mouse, which bears the same
ataxia and seizure phenotype as the Rocker mouse (probably
because of impaired transmitter release in both types of mice),
has no apparent structural neuropathology (19, 44). The phe-
notypes of these mutants are thus consistent with the idea that
Cav2, but not the  subunit, mediates a role in neuronal
growth. It seems likely that the role of Cav2 channels in neurite
outgrowth is linked to a reduction in calcium influx in growth
cones. Indeed, mammalian voltage-gated calcium channels are
known to play a role in spontaneous depolarization “transients”
that mediate axonal branching (53) and growth cone extension
and guidance to external cues (54). Although these transients
are reportedly dihydropyridine-sensitive (thus suggesting an
involvement of L-type channels), it is not yet clear to what
extent Cav2 channels may be involved in this phenomenon.
At this point, the significance of the absence of  subunits in
the periphery of growth cones and filopodia is unknown. It is
plausible, however, that the dynamic nature of the growth cone
requires a complement of highly motile calcium channel 1
subunits, in contrast with mature synaptic contacts where
FIG. 8. Identification of  subunit
mRNAs and local translation capac-
ity in Lymnaea neurites. A, localization
of 35S-dUTP-labeled antisense LCav
RNA in a diagonal tissue section through
cerebral ganglia and connecting commis-
sure. Note abundant staining in cell soma
(s) but detectable quantity also in neu-
rites (between white arrows). B, reverse
Northern blot containing spotted cDNA
fragments of Lymnaea Kv2.1 (KShab),
Kv3.1 (KShaw), and LCav1–3 and LCav,
probed with PCR-amplified 32P-labeled
cRNA from soma-ablated neurites (see il-
lustration in C and D). Note the selective
hybridization of LKv3 and LCav with
neuritic probe. C and D, illustration of
soma ablation with sterile glass pipette of
identified CGC neurons after 2 days in
culture. E, injection of the neurite shown
in C with mRNA of hemagglutinin-tagged
LCav followed by fixation and immuno-
histochemistry of neurite (F–H) after
12 h. Fluorescent secondary conjugates
were chosen to recognize a rat HA mono-
clonal antibody (F). Note that the staining
density is highest at the site of mRNA
injection. G, staining of neurite with anti-
rabbit LCav. H, superposition of F
and G.















calcium channels must be precisely and permanently localized
to the active zone. This would fit with the idea of the calcium
channel  subunit as a regulator of 1 subunit stability/mobil-
ity. Local protein synthesis in axons and dendrites provides
independence from the distant soma to support a rapid supply
of proteins for changing conditions in neurites, such as axonal
branching, growth cone guidance, and synapse formation (41,
42). Within this framework, the observation that the  subunit
can potentially be synthesized locally may provide a mecha-
nism by which this subunit could assemble with existing LCav2
channels following the establishment of synaptic contacts, thus
maintaining the precise localization of the 1 subunit in the
nerve terminal. It is also known that the induction of long term
potentiation activates the local translation of mRNA encoding
for factors that mediate synaptic plasticity (42). It is thus
tempting to speculate that the local synthesis of  subunits also
may be critical during depolarization-induced remodeling of
synapses.
It has been suggested that the  subunit masks an ER
retention signal on the 1 subunit that prevents efficient
plasma membrane targeting of the 1 subunit (18). If so, then
the observation that LCav2 1 subunits are uncoupled from 
subunits in growth cones would imply that  subunits dissoci-
ate from 1 subunits in growth cones. Alternatively, it is pos-
sible that membrane trafficking of 1 subunits can occur alto-
gether independently of  subunits. Indeed, although it is true
that surface expression of certain 1 subunits in transient
expression systems is increased with  subunits (18, 55), and
that  subunit knockout mice often have reduced calcium cur-
rent densities (5), there is no direct evidence for ER retention in
neurons. The differential localization of 1 and  subunits in
growth cones, together with the findings that membrane ex-
pression did not appear to be altered in tsA-201 cells following
LCav coexpression (i.e. current densities were unaffected) and
that robust membrane expression of LCav2 was observed in 
subunit antisense-depleted neurons, is also inconsistent with
LCav being required for efficient translocation of calcium
channels from the ER.
Divergence of  subunit sequences has permitted multiple
modulatory functions of  subunits, which act in a cell type and
calcium channel-specific manner (6, 7). However, the virtual
structural invariance of the  subunit core across divergent
species and its resemblance to a membrane-associated guany-
late kinase scaffolding molecule suggests that a primary role of
the  subunit may be to stabilize membrane protein complexes
associated with high voltage-activated calcium channels. Our
data show that in the central nervous system, Cav2 calcium
channels have both a role in mature synapses to mediate neu-
rotransmitter release (4) and an apparent role to regulate
growth of developing neurons. The differential association of 
subunits with synaptic calcium channels and those expressed
in emergent neuronal growth suggests that the  subunit may
mediate the transformation of Cav2 calcium channel function
in immature neurons and mature synapses.
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